Explore Pfizer’s evolving pipeline strategy, expanding into oncology and obesity to drive growth beyond its COVID-19 success.

A rise in tuberculosis cases in Malaysia triggered social media posts falsely claiming that the bacteria responsible for the ...

Feb 19 (Reuters) - German biopharmaceutical company BioNTech sued Moderna in Delaware federal court on Thursday, alleging ...

Commissioner Marty Makary defended his agency's position and record on mRNA vaccines, days after it changed course and agreed ...

By Ahmed Aboulenein WASHINGTON, Feb 23 (Reuters) - U.S. Food and Drug Administration Commissioner Marty Makary on Monday ...

European regulators have approved Moderna Inc.’s novel combination flu and Covid shot, handing a victory to the embattled ...

In August last year, the Health Department cut around $500 million in mRNA research funding, with Health Secretary Robert F.

BioNTech exploits a wide array of computational discovery and therapeutic modalities with the intent of rapid development of novel biopharmaceuticals. Its diversified portfolio of oncology product ...

Due to Pfizer’s underperformance relative to the healthcare sector over the past year, Wall Street analysts remain cautious about the stock’s prospects ...

Peter Sblendorio is a sports reporter covering MLB, the NFL, the NBA and more. He joined the Daily News in 2015 and previously served as the Senior Film Writer. Peter grew up in Dallas and graduated ...

Tempo fact check team's investigations into the deaths of the presidents of Haiti, Tanzania, and Burundi reveal no link to ...